059210 — Metabiomed Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩117bn
- KR₩141bn
- KR₩83bn
- 68
- 39
- 46
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3,573 | -4,090 | 9,662 | 3,600 | 9,815 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1,496 | 6,190 | -3,389 | 1,334 | -636 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5,902 | -1,138 | 1,320 | 394 | -3,156 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2,865 | 4,862 | 11,136 | 9,159 | 10,217 |
Capital Expenditures | -8,069 | -3,314 | -2,100 | -15,405 | -11,494 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 1,342 | -6,602 | 8,424 | 827 | -207 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -6,727 | -9,915 | 6,324 | -14,578 | -11,701 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 674 | 11,403 | -16,107 | 8,734 | -1,023 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3,138 | 6,288 | 1,474 | 3,113 | -2,430 |